In a retrospective cohort study published in Cardiovascular Diabetology, researchers identified a specific metabolic and inflammatory profile associated with significantly higher one-year all-cause mortality in critically ill patients with coronary heart disease. The study, which utilized data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database, focused on the combined prognostic value of two specific indices: the triglyceride glucose-body mass index (TyG-BMI) and the systemic inflammation response index (SIRI). The central finding indicates that patients presenting with low TyG-BMI and high SIRI levels faced a mortality risk more than double that of their counterparts with lower values for both markers.
The research addresses a gap in understanding how insulin resistance and systemic inflammation interact to drive coronary heart disease progression in intensive care settings. While insulin resistance and inflammation are recognized as key drivers of the disease, their combined prognostic value in critically ill patients had remained unknown prior to this investigation. The authors aimed to evaluate the independent and combined associations of these two surrogates with one-year all-cause mortality. TyG-BMI is described as a novel surrogate for insulin resistance, while SIRI reflects the global inflammatory burden within the body.
The study included a total of 1,546 critically ill coronary heart disease patients extracted from the MIMIC-IV database. The cohort was predominantly male, with 60.87% of participants identified as men. The mean age of the included patients was 70.90 years, with a standard deviation of 13.04 years. Over the one-year follow-up period, the overall mortality rate in this specific cohort was 37.45%, corresponding to 579 deaths.
Methodologically, the researchers employed Cox proportional hazards models and restricted cubic splines as primary analyses to assess the associations of continuous TyG-BMI and SIRI with one-year all-cause mortality. Formal interaction testing was included to determine if the two indices modified each other’s effects. Additionally, a four-group comparison based on median splits was performed as a secondary, exploratory analysis to illustrate descriptive risk patterns. This approach allowed the researchers to move beyond simple continuous associations and examine how specific combinations of high and low values might stratify risk.
In the primary continuous analyses, higher SIRI was associated with higher one-year mortality. Specifically, for every 0.1-unit increase in SIRI, the hazard ratio for mortality was 1.023, with a 95% confidence interval ranging from 1.018 to 1.027 and a p-value less than 0.0001. Conversely, higher TyG-BMI was associated with lower mortality, with a hazard ratio of 0.998 per unit increase, a 95% confidence interval of 0.997 to 0.999, and a p-value of 0.0008. The multiplicative interaction between TyG-BMI and SIRI was not statistically significant, with a p-value of 0.3668, suggesting that the effect of one index did not significantly depend on the level of the other in the continuous model.
The exploratory four-group analysis provided more distinct risk stratification. Using the median TyG-BMI of 277.66 and the median SIRI of 6.64 as cutoffs, patients were categorized into four groups. The group with TyG-BMI below the median and SIRI below the median served as the reference. Patients with TyG-BMI below the median but SIRI above the median exhibited the highest mortality risk, with a hazard ratio of 2.33, a 95% confidence interval of 1.85 to 2.94, and a p-value less than 0.0001. In contrast, those with TyG-BMI above the median and SIRI below the median had the lowest risk, with a hazard ratio of 0.65, a 95% confidence interval of 0.48 to 0.87, and a p-value of 0.0037.
Restricted cubic spline analysis revealed a significant non-linear relationship between SIRI and mortality, with a p-value for non-linearity less than 0.0001. The hazard ratio increased rapidly at low SIRI values, plateaued gradually, and declined slightly at higher values. In contrast, TyG-BMI showed no significant non-linear association with mortality, with a p-value of 0.1430.
The study also examined potential effect modification across various subgroups. No significant effect modification was observed across the tested subgroups, as all interaction p-values were greater than 0.05. This indicates that the association between the combined TyG-BMI and SIRI phenotype and mortality was consistent across different demographic and clinical subgroups within the cohort.
The authors conclude that in critically ill coronary heart disease patients, the combination of low TyG-BMI and high SIRI identifies a high-risk phenotype with more than double the one-year mortality risk. However, the study emphasizes that these findings are observational and derived from a single database. The authors note that these results require external validation before any clinical application can be considered, and whether incorporating these indices into routine risk assessment improves clinical decision-making remains to be determined through prospective validation.
Coronary heart disease remains a leading cause of death worldwide, with both insulin resistance and systemic inflammation recognized as fundamental drivers of its progression. Although earlier investigations examined these biological pathways separately, their simultaneous evaluation had not been conducted among patients requiring intensive care. By evaluating the triglyceride glucose-body mass index alongside the systemic inflammation response index upon hospital admission, the investigators sought to determine whether a dual metabolic-inflammatory profile could clarify long-term outcomes in this vulnerable population.
In this cohort of critically ill patients, higher continuous values of the triglyceride glucose-body mass index were associated with slightly reduced mortality risk, yielding a hazard ratio of 0.998 per unit increase. Nevertheless, the study authors explicitly caution against overinterpreting this paradox, emphasizing that the standalone signal for the insulin resistance surrogate remains inconsistent across different analytical models.
The dose-response analysis further illuminates how inflammatory burden relates to one-year survival through non-linear dynamics. Using restricted cubic splines, the researchers observed that mortality risk escalated steeply as systemic inflammation response index values rose from lower levels. After this initial sharp climb, the hazard ratio gradually plateaued before exhibiting a slight downward trajectory at the highest measured values. In contrast, the triglyceride glucose-body mass index displayed no departure from linearity, with a formal non-linearity test yielding a p-value of 0.1430. Furthermore, the absence of a statistically significant multiplicative interaction between the two continuous indices indicates that each factor contributed independently to the statistical model, and extensive subgroup testing confirmed that this general risk pattern remained stable without significant effect modification across tested patient categories.
Despite the strong associations observed within the MIMIC-IV cohort, the researchers emphasized crucial limitations regarding how these statistical associations should be interpreted. Because the investigation relied entirely on retrospective records from a single database, the results are fundamentally observational and hypothesis-generating rather than definitive evidence of clinical efficacy. The authors explicitly stated that external validation across diverse patient cohorts and distinct hospital environments is an essential prerequisite before these markers could be considered for any practical clinical role. Whether integrating these laboratory surrogates into routine intensive care admission workflows actually enhances risk prediction or refines clinical decision-making remains an open question that requires rigorous prospective evaluation in future clinical research.
Subject of Research: Association of TyG-BMI and SIRI with one-year mortality in critically ill coronary heart disease patients
Article Title: Association of low triglyceride glucose-body mass index (TyG-BMI) and high systemic inflammation response index (SIRI) with one-year all-cause mortality in critically ill patients with coronary heart disease: a retrospective cohort study from MIMIC-IV
Article References: Quan, L., Wu, S., Yang, M., Dong, F., Zeng, Z., Xu, H., Lu, X., Yu, G., Xu, X., & Liu, S. (2026). Association of low triglyceride glucose-body mass index (TyG-BMI) and high systemic inflammation response index (SIRI) with one-year all-cause mortality in critically ill patients with coronary heart disease: a retrospective cohort study from MIMIC-IV. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-026-03393-9
Image Credits: AI Generated
DOI: 10.1186/s12933-026-03393-9
Keywords: coronary heart disease, mortality risk, TyG-BMI, SIRI, insulin resistance, systemic inflammation, MIMIC-IV, retrospective cohort, critical care, prognostic markers, Association, triglyceride
News Source: Ophelia Keating. (November 7, 2026). Low TyG-BMI, High SIRI Linked to Mortality Risk. Scienmag.



